# US 2006/0153773 A1 · Contrast medium for mri

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0153773 A1
- Document ID: US20060153773A1
- Status: Published application
- Kind: A1
- Application number: 10/546,964
- Filed: 2004-02-03
- Published: 2006-07-13
- Earliest claimed: 2003-02-27
- Assignees: Kyushu University, National University Corporation
- Inventors: Yoshiki Katayama; Hiroaki Shimokawa; Tatsuhiro Yamamoto
- Web page: https://patentgrep.com/patent/US20060153773A1

## CPC

- A61K 49/085: {conjugated systems}
- A61K 49/10: Organic compounds
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

Disclosed is an MRI contrast agent which enables direct detection and imaging of exfoliated vascular endothelial sites. The MRI contrast agent comprises an imaging unit which contains an unpaired electron-carrying atom and/or molecule and is capable of amplifying or reducing MRI signals, and a detection unit which is bonded to said imaging unit and is capable of selectively recognizing exfoliated vascular endothelial sites and binding thereto. The detection unit is exemplified by one having a chemical structure expressed by the following formula (I), wherein at least one of R1-R11 is, for example, sulfonic acid group, and X is, for example, a phenyl group which may be substituted:

## Claims

### Claim 1

A contrast agent for use in MRI, comprising an imaging unit which contains an unpaired electron-carrying atom and/or molecule and is capable of amplifying or reducing MRI signals, and a detection unit which is bonded to said imaging unit and is capable of selectively recognizing exfoliated vascular endothelial sites and binding thereto.

### Claim 2 (depends on 1)

An MRI contrast agent as claimed in claim 1, in which the detection unit is one having a chemical structure expressed by the following general formula (I):
wherein at least one of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 may be independently sulfonic acid group, hydroxyl group or amino group, at least one of R1, R2, R3 and R4 may be independently an alkyl group or alkoxy group having 1 to 3 carbon atoms, the remaining ones of R1, R2, R3, R4, R5, R6, R7, R8, R9, R10 and R11 which do not fall within any of the above-mentioned functional groups are all hydrogen atom, and X, if present, represents a phenyl group in which at least one site may be substituted with an alkyl group or alkoxy group having 1 to 3 carbon atoms.

### Claim 3 (depends on 2)

An MRI contrast agent as claimed in claim 2, in which the detection unit is one having a chemical structure expressed by the following chemical formula (II), (III), (IV), (V) or (VI).

### Claim 4 (depends on 1)

An MRI contrast agent as claimed in any of claim 1, in which the imaging unit comprises a chelated complex of gadolinium.

### Claim 5 (depends on 4)

An MRI contrast agent as claimed in claim 4, which is expressed by the following chemical formula (VII):

### Claim 6 (depends on 2)

An MRI contrast agent as claimed in claim 2, in which the imaging unit comprises a chelated complex of gadolinium.

### Claim 7 (depends on 6)

An MRI contrast agent as claimed in claim 6, which is expressed by the following chemical formula (VIII):

### Claim 8 (depends on 3)

An MRI contrast agent as claimed in claim 3, in which the imaging unit comprises a chelated complex of gadolinium.

### Claim 9 (depends on 8)

An MRI contrast agent as claimed in claim 8, which is expressed by the following chemical formula (IX):
